# Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects

> **NCT02253342** · PHASE1 · COMPLETED · sponsor: **Wockhardt** · enrollment: 30 (actual)

## Conditions studied

- Intrapulmonary Pharmacokinetics of WCK 2349

## Interventions

- **DRUG:** WCK-2349

## Key facts

- **NCT ID:** NCT02253342
- **Lead sponsor:** Wockhardt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2014-12
- **Final completion:** 2015-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2015-10-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02253342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02253342, "Study to Determine and Compare Plasma and Intrapulmonary Pharmacokinetics of WCK 2349 in Healthy Adult Human Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02253342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*